MSD Animal Health Boosts Rabies Prevention with Major Vaccine Donation

MSD Animal Health, the veterinary division of Merck & Co., Inc., has reached a significant milestone by donating over six million NOBIVAC rabies vaccines through its global non-profit initiative, the Afya Program. This substantial contribution is aimed at battling rabies in endemic regions with limited access to crucial resources. Through this initiative, MSD Animal Health demonstrates its commitment to saving lives and eradicating a deadly yet preventable disease.

In many communities worldwide, rabies remains a persistent threat due to limited access to vaccines and resources. The Afya Program, supported by MSD Animal Health, focuses on vaccinating dogs in rabies-endemic areas to prevent outbreaks.

With the theme “Breaking Rabies Boundaries,” World Rabies Day 2024 highlights the critical need to overcome barriers in combating rabies. The Executive Director of International Veterinary Health at MSD Animal Health, emphasized the effectiveness of canine mass vaccination as the most cost-effective rabies prevention strategy, highlighting the direct correlation between vaccinating dogs and saving human lives.

Through its longstanding commitment, MSD Animal Health continues to lead the fight against rabies, underscoring the urgency of addressing this preventable disease. By actively contributing through the Afya Program, MSD Animal Health not only enhances public health initiatives but also reinforces its dedication to innovation and global health improvement, marking a pivotal step forward in the global effort to eliminate rabies.

For the latest updates and in-depth insights into the world of Animal Health, including breakthrough treatments, industry trends, and regulatory news, contact Poppy Hodge today!